Cross-reactivity in β-Lactam Allergy.
Zagursky RJ, Pichichero ME.
J Allergy Clin Immunol Pract · review; journal article · DOI 10.1016/j.jaip.2017.08.027 PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för cefepime. Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
40 träffarContact urticaria syndrome with IgE antibody against a cefotiam-unique structure, evoked by nonapparent exposure to cefotiam.
Takahagi S, Tanaka A, Iwamoto K, Ishii K, Hide M.
Clin Exp Dermatol · journal article; case reports · DOI 10.1111/ced.13126Synthetic approach to gain insight into antigenic determinants of cephalosporins: in vitro studies of chemical structure-IgE molecular recognition relationships.
Montannez MI, Mayorga C, Torres MJ, Ariza A, Blanca M, Perez-Inestrosa E.
Chem Res Toxicol · journal article · DOI 10.1021/tx100446gInfluence of plasma exchange on the disposition of the fourth generation cephalosporin cefepime.
Ibrahim RB, Liu CY, Cronin SM, Murphy BC, Cha R, Swerdlow P, Avila T, Smith ST, Lewis RA, Edwards DJ.
J Oncol Pharm Pract · research support, non-u.s. gov't; journal article · DOI 10.1177/1078155209103103Cefepime: a reappraisal in an era of increasing antimicrobial resistance.
Endimiani A, Perez F, Bonomo RA.
Expert Rev Anti Infect Ther · research support, non-u.s. gov't; research-article; review; research support, u.s. gov't, non-p.h.s.; journal article; research support, n.i.h., extramural · DOI 10.1586/14787210.6.6.805Renal failure is a risk factor for cefepime-induced encephalopathy.
Garces EO, Andrade de Anzambuja MF, da Silva D, Bragatti JA, Jacoby T, Saldanha Thomé F.
J Nephrol · comparative study; journal articleCefepime and its role in pediatric infections.
Shahid SK.
Recent Pat Antiinfect Drug Discov · review; journal article · DOI 10.2174/157489108784746614Phenotypic detection of extended-spectrum beta-lactamase production in Enterobacteriaceae: review and bench guide.
Drieux L, Brossier F, Sougakoff W, Jarlier V.
Clin Microbiol Infect · review; journal article · DOI 10.1111/j.1469-0691.2007.01846.x[Participation of metallo-beta-lactamases in resistance to imipenem and meropenem in clinical strains of Pseudomonas aeruginosa and Acinetobacter spp].
Sacha P, Wieczorek P, Jakoniuk P, Zórawski M.
Wiad Lek · journal articleAcquisition of rectal colonization by vancomycin-resistant Enterococcus among intensive care unit patients treated with piperacillin-tazobactam versus those receiving cefepime-containing antibiotic regimens.
Paterson DL, Muto CA, Ndirangu M, Linden PK, Potoski BA, Capitano B, Bonomo RA, Aron DC, Donskey CJ.
Antimicrob Agents Chemother · research support, non-u.s. gov't; research-article; research support, u.s. gov't, non-p.h.s.; journal article · DOI 10.1128/aac.01316-06Efficacy and safety of cefepime: a systematic review and meta-analysis.
Yahav D, Paul M, Fraser A, Sarid N, Leibovici L.
Lancet Infect Dis · meta-analysis; systematic review; journal article · DOI 10.1016/s1473-3099(07)70109-3Cefepime restriction improves gram-negative overall resistance patterns in neonatal intensive care unit.
de Araujo OR, da Silva DC, Diegues AR, Arkader R, Cabral EA, Afonso MR, Louzada ME, Albertoni Ade C.
Braz J Infect Dis · research support, non-u.s. gov't; journal article · DOI 10.1590/s1413-86702007000200022Selective immediate hypersensitivity to cefepime.
Moreno E, Dávila I, Laffond E, Macías E, Isidoro M, Ruiz A, Lorente F.
J Investig Allergol Clin Immunol · clinical trial; journal article; case reportsAcute neurological deficits caused by cefipime: a case report and review of literature.
Lin CM, Chen YM, Po HL, Hseuh IH.
Acta Neurol Taiwan · journal article; case reportsDevelopment and in-house validation of a microbiological assay for determination of cefepime in injectable preparations.
Souza MJ, Kulmann RR, Silva LM, Nogueira DR, Zimmermann ES, Schmidt CA.
J AOAC Int · comparative study; validation study; journal article · DOI 10.1093/jaoac/89.5.1367Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
Jones RN, Sader HS, Fritsche TR, Pottumarthy S.
Diagn Microbiol Infect Dis · comparative study; journal article · DOI 10.1016/j.diagmicrobio.2006.06.011Effect of antibiotic heterogeneity on the development of infections with antibiotic-resistant gram-negative organisms in a non-intensive care unit surgical ward.
Takesue Y, Ohge H, Sakashita M, Sudo T, Murakami Y, Uemura K, Sueda T.
World J Surg · research support, non-u.s. gov't; journal article · DOI 10.1007/s00268-005-0781-7Antimicrobial activity of cefepime tested against ceftazidime-resistant Gram-negative clinical strains from North American Hospitals: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
Pfaller MA, Sader HS, Fritsche TR, Jones RN.
Diagn Microbiol Infect Dis · multicenter study; journal article · DOI 10.1016/j.diagmicrobio.2006.02.009SHV-type extended-spectrum beta-lactamase production is associated with Reduced cefepime susceptibility in Enterobacter cloacae.
Szabó D, Bonomo RA, Silveira F, Pasculle AW, Baxter C, Linden PK, Hujer AM, Hujer KM, Deeley K, Paterson DL.
J Clin Microbiol · research support, u.s. gov't, p.h.s.; research-article; research support, u.s. gov't, non-p.h.s.; journal article; research support, n.i.h., extramural · DOI 10.1128/jcm.43.10.5058-5064.2005Population pharmacokinetics of cefepime in the neonate.
Capparelli E, Hochwald C, Rasmussen M, Parham A, Bradley J, Moya F.
Antimicrob Agents Chemother · research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1128/aac.49.7.2760-2766.2005Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients.
Isla A, Gascón AR, Maynar J, Arzuaga A, Toral D, Pedraz JL.
Clin Ther · research support, non-u.s. gov't; journal article · DOI 10.1016/j.clinthera.2005.05.004[Cefepime-induced encephalopathy: clinical and electroencephalographic features in seven patients].
Bragatti JA, Rossato R, Ziomkowski S, Kliemann FA.
Arq Neuropsiquiatr · journal article · DOI 10.1590/s0004-282x2005000100016Stability of cefepime in icodextrin peritoneal dialysis solution.
Elwell RJ, Volino LR, Frye RF.
Ann Pharmacother · journal article · DOI 10.1345/aph.1e324Antimicrobial susceptibility survey of Pseudomonas aeruginosa strains isolated from clinical sources.
Orrett FA.
J Natl Med Assoc · multicenter study; journal articleSynthesis and biological activities of diflunisal hydrazide-hydrazones.
Küçükgüzel SG, Mazi A, Sahin F, Oztürk S, Stables J.
Eur J Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1016/j.ejmech.2003.08.004Is there a rationale for the continuous infusion of cefepime? A multidisciplinary approach.
Bernard E, Breilh D, Bru JP, Chiche D, Dujardin I, Garraffo R, Goldstein F, Lavrard I, Potel G.
Clin Microbiol Infect · review; journal article · DOI 10.1046/j.1469-0691.2003.00587.x[Experience with maxipime in neurosurgical clinic].
Kondrat'ev AN, Ivchenko IM.
Antibiot Khimioter · comparative study; clinical trial; journal articleAlteration of pore properties of Escherichia coli OmpF induced by mutation of key residues in anti-loop 3 region.
Bredin J, Saint N, Malléa M, Dé E, Molle G, Pagès JM, Simonet V.
Biochem J · research support, non-u.s. gov't; research-article; journal article · DOI 10.1042/0264-6021:3630521Pharmacodynamic considerations in the treatment of moderate to severe pseudomonal infections with cefepime.
Ambrose PG, Owens RC, Garvey MJ, Jones RN.
J Antimicrob Chemother · review; journal article · DOI 10.1093/jac/49.3.445Cefepime versus vancomycin plus netilmicin therapy for continuous ambulatory peritoneal dialysis-associated peritonitis.
Wong KM, Chan YH, Cheung CY, Chak WL, Choi KS, Leung SH, Leung J, Chau KF, Tsang DN, Li CS.
Am J Kidney Dis · clinical trial; randomized controlled trial; journal article · DOI 10.1053/ajkd.2001.25205